Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Harvard Business School
Chinese Patent Office
Teva
Moodys
Fuji
Federal Trade Commission
Colorcon
US Army
Merck
Farmers Insurance

Generated: August 19, 2017

DrugPatentWatch Database Preview

Tolbutamide - Generic Drug Details

« Back to Dashboard

What are the generic sources for tolbutamide and what is the scope of tolbutamide patent protection?

Tolbutamide
is the generic ingredient in three branded drugs marketed by Watson Labs, Barr, Dava Pharms Inc, Alra, Ascot, Mylan Pharms Inc, Parke Davis, Purepac Pharm, Pharmacia And Upjohn, Sandoz, Vangard, Ivax Pharms, and Superpharm, and is included in eighteen NDAs. Additional information is available in the individual branded drug profile pages.

There are fifteen drug master file entries for tolbutamide. One supplier is listed for this compound.

Summary for Generic Name: tolbutamide

Tradenames:3
Patents:0
Applicants:13
NDAs:18
Drug Master File Entries: see list15
Suppliers / Packagers: see list1
Bulk Api Vendors: see list65
Clinical Trials: see list22
Patent Applications: see list6,216
Therapeutic Class:Blood Glucose Regulators
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:tolbutamide at DailyMed

Pharmacology for Ingredient: tolbutamide

Ingredient-typeSulfonylurea Compounds
Drug ClassSulfonylurea
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Purepac Pharm
TOLBUTAMIDE
tolbutamide
TABLET;ORAL088950-001Jun 17, 1985DISCNNoNo► Subscribe► Subscribe► Subscribe
Pharmacia And Upjohn
ORINASE
tolbutamide
TABLET;ORAL010670-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Ascot
TOLBUTAMIDE
tolbutamide
TABLET;ORAL087541-001Mar 1, 1983DISCNNoNo► Subscribe► Subscribe► Subscribe
Watson Labs
TOLBUTAMIDE
tolbutamide
TABLET;ORAL089110-001May 29, 1987DISCNNoNo► Subscribe► Subscribe► Subscribe
Pharmacia And Upjohn
ORINASE
tolbutamide
TABLET;ORAL010670-002Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Covington
Accenture
Dow
Cerilliant
Harvard Business School
QuintilesIMS
McKinsey
Deloitte
UBS
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot